Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Critical Care Outcomes of Patients With Hematologic Malignancy and Hematopoietic Cell Transplantation

NCT03449953 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.

NCT NCT03449953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03449953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Critical Care Outcomes of Patients With Hematologic Malignancy and Hematopoietic Cell Transplantation
Lead sponsor
Mount Sinai Hospital, Canada
Phase
Observational
Overall status
Active, not recruiting
Start date
February 26, 2018
Completion date
December 31, 2026
Enrollment
415 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic malignancy, stem cell transplant